TY - JOUR AU - Smolen, J. S. AU - Aletaha, D. AU - McInnes, I. B. PY - 2016 DA - 2016// TI - Rheumatoid arthritis JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)30173-8 DO - 10.1016/S0140-6736(16)30173-8 ID - Smolen2016 ER - TY - JOUR AU - MacGregor, A. J. AU - Riste, L. K. AU - Hazes, J. M. AU - Silman, A. J. PY - 1994 DA - 1994// TI - Low prevalence of rheumatoid arthritis in black-Caribbeans compared with whites in inner city Manchester JO - Ann Rheum Dis VL - 53 UR - https://doi.org/10.1136/ard.53.5.293 DO - 10.1136/ard.53.5.293 ID - MacGregor1994 ER - TY - JOUR AU - Oliver, J. E. AU - Silman, A. J. PY - 2009 DA - 2009// TI - Why are women predisposed to autoimmune rheumatic diseases? JO - Arthritis Res Ther VL - 11 UR - https://doi.org/10.1186/ar2825 DO - 10.1186/ar2825 ID - Oliver2009 ER - TY - JOUR AU - Geiler, J. AU - Buch, M. AU - McDermott, M. F. PY - 2011 DA - 2011// TI - Anti-TNF treatment in rheumatoid arthritis JO - Curr Pharm Des VL - 17 UR - https://doi.org/10.2174/138161211798157658 DO - 10.2174/138161211798157658 ID - Geiler2011 ER - TY - JOUR AU - Atzeni, F. AU - Gianturco, L. AU - Talotta, R. AU - Varisco, V. AU - Ditto, M. C. AU - Turiel, M. PY - 2015 DA - 2015// TI - Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? JO - Immunotherapy VL - 7 UR - https://doi.org/10.2217/imt.15.4 DO - 10.2217/imt.15.4 ID - Atzeni2015 ER - TY - JOUR AU - Furst, D. E. AU - Keystone, E. C. AU - So, A. K. AU - Braun, J. AU - Breedveld, F. C. AU - Burmester, G. R. PY - 2013 DA - 2013// TI - Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012 JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2013-203348 DO - 10.1136/annrheumdis-2013-203348 ID - Furst2013 ER - TY - JOUR AU - Aaltonen, K. J. AU - Virkki, L. M. AU - Malmivaara, A. AU - Konttinen, Y. T. AU - Nordstrom, D. C. AU - Blom, M. PY - 2012 DA - 2012// TI - Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0030275 DO - 10.1371/journal.pone.0030275 ID - Aaltonen2012 ER - TY - JOUR AU - Singh, J. A. AU - Hossain, A. AU - Mudano, A. S. AU - Tanjong Ghogomu, E. AU - Suarez-Almazor, M. E. AU - Buchbinder, R. PY - 2017 DA - 2017// TI - Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis JO - Cochrane Database Syst Rev VL - 5 ID - Singh2017 ER - TY - JOUR AU - Vollenhoven, R. F. AU - Ostergaard, M. AU - Leirisalo-Repo, M. AU - Uhlig, T. AU - Jansson, M. AU - Larsson, E. PY - 2015 DA - 2015// TI - Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2014-205726 DO - 10.1136/annrheumdis-2014-205726 ID - Vollenhoven2015 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. PY - 1988 DA - 1988// TI - The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - JOUR AU - Aletaha, D. AU - Neogi, T. AU - Silman, A. J. AU - Funovits, J. AU - Felson, D. T. AU - Bingham, C. O. PY - 2010 DA - 2010// TI - 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2010.138461 DO - 10.1136/ard.2010.138461 ID - Aletaha2010 ER - TY - JOUR AU - Oremus, M. AU - Wolfson, C. AU - Perrault, A. AU - Demers, L. AU - Momoli, F. AU - Moride, Y. PY - 2001 DA - 2001// TI - Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials JO - Dement Geriatr Cogn Disord VL - 12 UR - https://doi.org/10.1159/000051263 DO - 10.1159/000051263 ID - Oremus2001 ER - TY - JOUR AU - Zeng, X. AU - Zhang, Y. AU - Kwong, J. S. AU - Zhang, C. AU - Li, S. AU - Sun, F. PY - 2015 DA - 2015// TI - The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review JO - J Evid Based Med VL - 8 UR - https://doi.org/10.1111/jebm.12141 DO - 10.1111/jebm.12141 ID - Zeng2015 ER - TY - BOOK AU - Sutton, A. J. AU - Abrams, K. R. AU - Jones, D. R. AU - Jones, D. R. AU - Sheldon, T. A. AU - Song, F. PY - 2000 DA - 2000// TI - Methods for meta-analysis in medical research: Wiley Chichester ID - Sutton2000 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Cochran, K. W. AU - Brown, G. C. AU - Francis, T. PY - 1954 DA - 1954// TI - Antiviral action of a mold filtrate on experimental poliomyelitis in cynomolgus monkeys JO - Proc Soc Exp Biol Med VL - 85 UR - https://doi.org/10.3181/00379727-85-20799 DO - 10.3181/00379727-85-20799 ID - Cochran1954 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - Higgins2002 ER - TY - STD TI - Light RJ, Pillemer DB. Summing up: The science of reviewing research. Cambridge: Harvard University; Press. 1984. ID - ref18 ER - TY - JOUR AU - Duval, S. AU - Tweedie, R. PY - 2000 DA - 2000// TI - Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis JO - Biometrics VL - 56 UR - https://doi.org/10.1111/j.0006-341X.2000.00455.x DO - 10.1111/j.0006-341X.2000.00455.x ID - Duval2000 ER - TY - JOUR AU - Bolge, S. C. AU - Goren, A. AU - Tandon, N. PY - 2015 DA - 2015// TI - Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective JO - Patient Prefer Adherence VL - 9 UR - https://doi.org/10.2147/PPA.S70834 DO - 10.2147/PPA.S70834 ID - Bolge2015 ER - TY - JOUR AU - Ramiro, S. AU - Landewe, R. AU - Heijde, D. AU - Harrison, D. AU - Collier, D. AU - Michaud, K. PY - 2015 DA - 2015// TI - Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors? JO - RMD Open VL - 1 UR - https://doi.org/10.1136/rmdopen-2015-000155 DO - 10.1136/rmdopen-2015-000155 ID - Ramiro2015 ER - TY - JOUR AU - Hetland, M. L. AU - Christensen, I. J. AU - Tarp, U. AU - Dreyer, L. AU - Hansen, A. AU - Hansen, I. T. PY - 2010 DA - 2010// TI - Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27227 DO - 10.1002/art.27227 ID - Hetland2010 ER - TY - JOUR AU - Gomez-Reino, J. J. AU - Carmona, L. PY - 2006 DA - 2006// TI - Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period JO - Arthritis Res Ther VL - 8 UR - https://doi.org/10.1186/ar1881 DO - 10.1186/ar1881 ID - Gomez-Reino2006 ER - TY - JOUR AU - Kuijper, T. M. AU - Lamers-Karnebeek, F. B. AU - Jacobs, J. W. AU - Hazes, J. M. AU - Luime, J. J. PY - 2015 DA - 2015// TI - Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: a systematic review JO - J Rheumatol VL - 42 UR - https://doi.org/10.3899/jrheum.141520 DO - 10.3899/jrheum.141520 ID - Kuijper2015 ER - TY - STD TI - Galvao TF, Zimmermann IR, da Mota LM, Silva MT, Pereira MG. Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2016;35(7):1659–68. ID - ref25 ER - TY - JOUR AU - Wolde, S. AU - Breedveld, F. C. AU - Hermans, J. AU - Vandenbroucke, J. P. AU - Laar, M. A. AU - Markusse, H. M. PY - 1996 DA - 1996// TI - Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis JO - Lancet VL - 347 UR - https://doi.org/10.1016/S0140-6736(96)90535-8 DO - 10.1016/S0140-6736(96)90535-8 ID - Wolde1996 ER - TY - JOUR AU - Ahern, M. J. AU - Hall, N. D. AU - Case, K. AU - Maddison, P. J. PY - 1984 DA - 1984// TI - D-penicillamine withdrawal in rheumatoid arthritis JO - Ann Rheum Dis VL - 43 UR - https://doi.org/10.1136/ard.43.2.213 DO - 10.1136/ard.43.2.213 ID - Ahern1984 ER - TY - JOUR AU - Silva, M. AU - Hazleman, B. L. PY - 1981 DA - 1981// TI - Long-term azathioprine in rheumatoid arthritis: a double-blind study JO - Ann Rheum Dis VL - 40 UR - https://doi.org/10.1136/ard.40.6.560 DO - 10.1136/ard.40.6.560 ID - Silva1981 ER - TY - JOUR AU - Kremer, J. M. AU - Rynes, R. I. AU - Bartholomew, L. E. PY - 1987 DA - 1987// TI - Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study JO - Am J Med VL - 82 UR - https://doi.org/10.1016/0002-9343(87)90015-5 DO - 10.1016/0002-9343(87)90015-5 ID - Kremer1987 ER - TY - JOUR AU - Prevoo, M. L. AU - 't Hof, M. A. AU - Kuper, H. H. AU - Leeuwen, M. A. AU - Putte, L. B. AU - Riel, P. L. PY - 1995 DA - 1995// TI - Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380107 DO - 10.1002/art.1780380107 ID - Prevoo1995 ER - TY - JOUR AU - Sewerin, P. AU - Vordenbaeumen, S. AU - Hoyer, A. AU - Brinks, R. AU - Buchbender, C. AU - Miese, F. PY - 2017 DA - 2017// TI - Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort JO - BMC Musculoskelet Disord VL - 18 UR - https://doi.org/10.1186/s12891-017-1528-y DO - 10.1186/s12891-017-1528-y ID - Sewerin2017 ER - TY - JOUR AU - Quinn, M. A. AU - Conaghan, P. G. AU - O'Connor, P. J. AU - Karim, Z. AU - Greenstein, A. AU - Brown, A. PY - 2005 DA - 2005// TI - Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.20712 DO - 10.1002/art.20712 ID - Quinn2005 ER - TY - JOUR AU - Nawata, M. AU - Saito, K. AU - Nakayamada, S. AU - Tanaka, Y. PY - 2008 DA - 2008// TI - Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission JO - Mod Rheumatol VL - 18 UR - https://doi.org/10.3109/s10165-008-0089-1 DO - 10.3109/s10165-008-0089-1 ID - Nawata2008 ER - TY - JOUR AU - Brocq, O. AU - Millasseau, E. AU - Albert, C. AU - Grisot, C. AU - Flory, P. AU - Roux, C. H. PY - 2009 DA - 2009// TI - Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis JO - Joint Bone Spine VL - 76 UR - https://doi.org/10.1016/j.jbspin.2008.11.009 DO - 10.1016/j.jbspin.2008.11.009 ID - Brocq2009 ER - TY - JOUR AU - Tanaka, Y. AU - Takeuchi, T. AU - Mimori, T. AU - Saito, K. AU - Nawata, M. AU - Kameda, H. PY - 2010 DA - 2010// TI - Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.121491 DO - 10.1136/ard.2009.121491 ID - Tanaka2010 ER - TY - STD TI - van den Broek M. Treat to target in rheumatoid arthritis : opportunities and outcomes [doctoral thesis]: Leiden University; 2013. ID - ref36 ER - TY - JOUR AU - Maas, A. AU - Kievit, W. AU - Bemt, B. J. AU - Hoogen, F. H. AU - Riel, P. L. AU - Broeder, A. A. PY - 2012 DA - 2012// TI - Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200945 DO - 10.1136/annrheumdis-2011-200945 ID - Maas2012 ER - TY - JOUR AU - Harigai, M. AU - Takeuchi, T. AU - Tanaka, Y. AU - Matsubara, T. AU - Yamanaka, H. AU - Miyasaka, N. PY - 2012 DA - 2012// TI - Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity JO - Mod Rheumatol VL - 22 UR - https://doi.org/10.3109/s10165-011-0586-5 DO - 10.3109/s10165-011-0586-5 ID - Harigai2012 ER - TY - JOUR AU - Hirata, S. AU - Saito, K. AU - Kubo, S. AU - Fukuyo, S. AU - Mizuno, Y. AU - Iwata, S. PY - 2013 DA - 2013// TI - Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study JO - Arthritis Res Ther VL - 15 UR - https://doi.org/10.1186/ar4315 DO - 10.1186/ar4315 ID - Hirata2013 ER - TY - JOUR AU - Smolen, J. S. AU - Nash, P. AU - Durez, P. AU - Hall, S. AU - Ilivanova, E. AU - Irazoque-Palazuelos, F. PY - 2013 DA - 2013// TI - Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61811-X DO - 10.1016/S0140-6736(12)61811-X ID - Smolen2013 ER - TY - JOUR AU - Iwamoto, T. AU - Ikeda, K. AU - Hosokawa, J. AU - Yamagata, M. AU - Tanaka, S. AU - Norimoto, A. PY - 2014 DA - 2014// TI - Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation JO - Arthritis Care Res VL - 66 UR - https://doi.org/10.1002/acr.22303 DO - 10.1002/acr.22303 ID - Iwamoto2014 ER - TY - JOUR AU - Kadar, G. AU - Balazs, E. AU - Soos, B. AU - Laduver, A. AU - Keszthelyi, P. AU - Szekanecz, Z. PY - 2014 DA - 2014// TI - Disease activity after the discontinuation of biological therapy in inflammatory rheumatic diseases JO - Clin Rheumatol VL - 33 UR - https://doi.org/10.1007/s10067-014-2508-3 DO - 10.1007/s10067-014-2508-3 ID - Kadar2014 ER - TY - JOUR AU - Tanaka, Y. AU - Hirata, S. AU - Kubo, S. AU - Fukuyo, S. AU - Hanami, K. AU - Sawamukai, N. PY - 2015 DA - 2015// TI - Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204016 DO - 10.1136/annrheumdis-2013-204016 ID - Tanaka2015 ER - TY - JOUR AU - Ghiti Moghadam, M. AU - Vonkeman, H. E. AU - Klooster, P. M. AU - Tekstra, J. AU - Schaardenburg, D. AU - Starmans-Kool, M. PY - 2016 DA - 2016// TI - Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial JO - Arthritis Rheumatol VL - 68 UR - https://doi.org/10.1002/art.39626 DO - 10.1002/art.39626 ID - Ghiti Moghadam2016 ER -